Atezolizumab vs Montelukast

## Atezolizumab vs Montelukast: Overview

This comparison examines the pharmacological differences between **Atezolizumab** and **Montelukast**.

## Mechanism of Action

**Atezolizumab**: Fully human anti-PD-L1 IgG1 monoclonal antibody blocking PD-L1 interaction with PD-1 and B7.1.

**Montelukast**: Selective leukotriene D4 receptor antagonist.

## Pharmacokinetics

**Half-life**: Atezolizumab — 27 days; Montelukast — 2.7-5.5 hours.

## Chemical Properties

**Molecular Formula**: Atezolizumab — N/A; Montelukast — C35H36ClNO3S.

**Molecular Weight**: Atezolizumab — N/A; Montelukast — 586.1800 g/mol.

**Type**: Atezolizumab — Antibody; Montelukast — Small molecule.